Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,373.18 644.93 Cost of selling medical equipment 166.98 94.11
1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of...
million decreased by Baht 303.39 million, or 16.42% from the previous year, mainly from the decrease of branches from 106 branches to 97 branches. 2. The Company’ s cost of goods sold in the year 2018 were
increased from THB 82.00 million to THB 133.61 million or increased THB 51.61 million or 62.94% because film production and films rights distribution generated more revenue than last year. Cost and expense of
compared with Q3 year 2017. Cost of Sales for Q3 year 2018 and Q3 year 2017 was 355.25 million baht and 331.79 million baht, respectively. It increased 23.45 million baht or 7.07% when compared with Q3 year
price that decreased due to the global economic slowdown as a result of trade protection measures between China and the United States. - The company has cost of sales of 616.03 million baht or 84.14% of
Activity report 2017En CAPITAL MARKET FOR ALL INDEPENDENT AUDIT INSPECTION ACTIVITIES REPORT 2017 INDEPENDENT AUDIT INSPECTION ACTIVITIES REPORT 2017 Executive Summary Quality Assurance Review Panel Activities for Enhancing Financial Reporting Quality Framework and Focuses in 2018 Root Cause Analysis Summary of Audit Inspection Results A. Firm Level B. Engagement Level Essential Statistics 49 4412 46 0402 07 Contents Executive Summary The capital market is a fundamental component in driving Thai...
than the registered value of both categories of shares shall be separately demonstrated. 23. Appraisal surplus means a premium on cost or book value of the asset. 24. Revaluation surplus (deficit) in
part lower than the registered value of both categories of shares shall be separately demonstrated. 23. Appraisal surplus means a premium on cost or book value of the asset. 24. Revaluation surplus